Deep Dive: Advances in the Care of Infectious Diseases in the ICU-Introduction

Video Transcription

Video Summary

Infectious diseases have a significant impact in critical care medicine, with infection being one of the most prevalent conditions in ICUs globally. The EPIC-3 study, conducted in 2020, found that 54% of patients in the ICU had a suspected or confirmed infection. Antimicrobial drug therapy was heavily used, with 70% of patients receiving one or more antimicrobial drugs. The mortality rate among infected patients was 30%. Future threats in critical care medicine include antimicrobial resistance, emerging infectious diseases, challenges with diagnostics, and detecting sepsis. However, there are advances in the form of new antimicrobial drugs, biomarkers, rapid diagnostics, and improved systems of care for high-consequence pathogens. This session focuses on novel systems, technologies, and approaches for caring for infected patients in the ICU.

Asset Caption

Ryan C. Maves

Keywords

Infectious diseases

critical care medicine

ICU

antimicrobial drug therapy

mortality rate

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.